skip to Main Content

February 14, 2020
An Activist’s Guide to the LAM Test
Publication
Tuberculosis (TB) is the number one killer of people living with HIV/AIDS, causing one in three of all AIDS-related deaths. People living with HIV are at increased risk of developing TB, and of dying from it—especially when they have advanced HIV disease, or AIDS. The LAM test can rapidly and…

January 24, 2020
TAG Comment on the Trans-NIH Strategic Plan Goals for Sexual & Gender Minority (SGM) Health Research
Letter / Comment
TAG submitted this public comment in response to a Request for Information on the Development of the Fiscal Year 2021-2025 Trans-NIH Strategic Plan for Sexual & Gender Minority Health Research, affirming the need for a research agenda that will best address HIV, TB, and HCV among LGBTQ+ communities and incorporate…

January 22, 2020
Good COPs or Bad COPs: Promoting Interventions for Coinfections and AIDS in 2020 PEPFAR Country Operational Plans (COPs)
Webinar / Presentation
On January 22, 2020, Treatment Action Group (TAG), Médecins Sans Frontières (MSF) Access Campaign, Health GAP, IMPAACT4TB, and AVAC presented this webinar on how to engage in PEPFAR COPs advocacy. Materials are online now.

January 22, 2020
Sanofi Withdraws Two Patent Applications on Life-Saving Tuberculosis Prevention Drugs in Europe and in Indonesia
Statement / Press
Follow up to our 12/19 statement applauding Indian activists for taking legal action to oppose two patent applications filed by Sanofi in India. This joint statement from Treatment Action Group and OTMeds urges Sanofi to deliver on its promise to withdraw in all countries where the applications were filed and…

January 9, 2020
After Cuomo Speech, NY Health Orgs Including TAG Warn that Governor’s Health Plan Falls Short
Statement / Press
TAG, as part of the Save NY Public Health Campaign, called out Governor Cuomo’s recently announced Medicaid cuts and other failures to adequately address health and health equity in his January 8, 2020 “State of the State” address.

January 6, 2020
Open Letter: Time to Lower the Price of Xpert Cartridges to $5
Letter / Comment
TAG joined 156 organizations and individuals to demand that Cepheid lower the price of Xpert tests for TB, HIV, HCV and other diseases to improve access to rapid, accurate diagnostic testing.

December 16, 2019
TAG Comment on Cures 2.0 Call to Action
Letter / Comment
TAG submitted comments to the offices of Representative Diana DeGette and Representative Fred Upton in response to their call to action regarding a 21st Century Cures Act 2.0 legislation. This proposed Cures 2.0 legislation must strengthen FDA’s stringent regulatory authority to ensure that medicines are safe, effective, and accessible for…

December 10, 2019
2019 TAG Update
Publication
TAG’s work in 2019 demonstrated our leadership towards an end to HIV, hepatitis C, and tuberculosis through hard-hitting, science-based activism. Excerpts of the media coverage we received walk you through a remarkable year of TAG’s work.

December 10, 2019
2019 Report on TB Research Funding Trends
TB R&D Report
TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005.

December 5, 2019
Treatment Action Group Applauds Indian TB Activists in Opposing Patents for Critical TB Prevention Drugs
Statement / Press
Treatment Action Group (TAG) applauds the legal actions undertaken by our colleagues from the Delhi Network of Positive People (DNP+) and tuberculosis (TB) survivor and activist Ganesh Acharya of Mumbai, with support from the Third World Network (TWN), contesting two patent applications on combinations of two decades-old TB medicines filed…

Back To Top